Advik Pharmaa Financials

BSE: 531686

₹1.99

₹0.00 (0.00%)

As on 31-Aug-2026IST

Market cap

₹4 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

--

P/B Ratio

-21.3

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	--	--	--	--	0.03	--
Total Income	0.04	0.05	0.09	0.02	0.29	0.20
Total Expenditure	0.96	0.76	0.80	0.95	0.71	4.13
EBITDA	-0.96	-0.76	-0.80	-0.95	-0.67	-4.13
Depreciation	0.15	0.15	0.15	0.15	0.51	0.56
EBIT	-1.10	-0.91	-0.95	-1.09	-1.19	-4.69
Interest	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.04	0.05	0.09	0.02	0.26	0.20
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-1.07	-0.86	-0.85	-1.07	-0.93	-4.49
Provision for Tax	-0.03	0.03	-0.02	-0.02	-0.79	-0.08
Profit after Tax	-1.04	-0.90	-0.83	-1.05	-0.14	-4.42

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	0.07	1.08	1.97	2.79	3.83	3.95
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.22	0.18	0.22	0.23	0.25	0.69
Current Liabilities	8.19	8.07	7.74	7.17	6.08	6.66
Total Liabilities	8.48	9.33	9.94	10.19	10.16	11.30

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	6.61	7.28	7.81	8.08	8.13	9.11
Current Assets	1.87	2.05	2.12	2.10	2.03	2.19
Total Assets	8.48	9.33	9.94	10.19	10.16	11.30
Total Debt*	--	7.46	7.27	6.76	5.81	5.68
Net Current Assets	-6.32	-6.02	-5.62	-5.06	-4.05	-4.47
Contingent Liabilities	--	0.04	0.04	0.04	0.04	0.04

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	-0.57	-0.63	-0.87	-4.34	-0.93
Cash Flow from Investing Activities	--	0.38	0.12	-0.10	0.46	1.54
Cash from Financing Activities	--	0.18	0.51	0.96	3.88	-0.61
Net Cash Inflow / Outflow	--	0.00	0.00	-0.01	0.00	0.00

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	-0.54	-0.47	-0.43	-0.55	-0.07	-2.31
Cash EPS (₹)	--	-0.39	-0.36	-0.47	0.19	-2.02
Adjusted Book Value (₹)	--	0.57	1.03	1.46	2.00	2.07
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-0.30	-0.33	-0.45	-2.27	-0.49
Free Cash Flow per Share (₹)	--	-0.31	-0.33	-0.51	-2.06	-0.46

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	-9.70	-9.06	-11.15	-9.64	-36.90
ROE (%)	-291.44	-58.89	-34.92	-31.75	-3.64	-71.73
ROA (%)	-11.67	-9.32	-8.26	-10.33	-1.32	-31.87
EBIT Margin (%)	--	--	--	--	-3,665.85	--
Net Margin (%)	-2,886.11	-1,881.58	-887.23	-4,508.10	-48.72	-2,262.52
Cash Profit Margin (%)	--	--	--	--	1,149.13	--

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	--	--	--	-100.00	--	-100.00
EBIT Growth (%)	-21.48	3.68	13.55	7.89	74.67	-276.21
Net Profit Growth (%)	-15.96	-8.05	20.88	-641.90	96.79	-278.50
EPS Growth (%)	-15.93	-8.05	20.89	-641.70	96.79	-278.46
Book Value Growth (%)	--	-45.11	-29.47	-27.05	-3.15	-52.76

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	--	--	--	--	--	--
Price / Book Value	-21.33	5.62	3.12	1.44	0.69	0.36
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-12.30	-18.91	-19.02	-11.66	-20.36	-1.80
Close Price (₹)	1.81	3.18	3.21	2.10	1.39	0.75
High Price (₹)	3.01	4.33	3.21	2.10	1.39	0.75
Low Price (₹)	1.57	3.05	2.10	1.39	0.72	0.37
Market Cap (₹ Cr)	3.80	--	--	--	2.66	--

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	--	6.90	3.69	2.42	1.52	1.44
Short term debt to equity ratio	--	6.90	3.69	2.42	1.52	0.49
Current Ratio	0.23	0.25	0.27	0.29	0.33	0.33
Quick Ratio	0.19	0.19	0.21	0.22	0.24	0.24
Interest Coverage	-1,067.00	-685.52	-448.07	-990.71	-241.16	-1,520.41

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	--	--	--	--	106.77	--
Asset Turnover	--	--	--	--	0.00	--
Receivable days	--	--	--	--	3,546.47	--
Inventory Days	--	--	--	--	6,293.93	--
Payable days	--	--	--	1,303.80	769.80	--
Cash Conversion Cycle	--	--	--	--	9,070.61	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.